RecruitingEarly Phase 1NCT07017478

Mood Effects of Serotonin Agonists: Depression


Sponsor

University of Chicago

Enrollment

48 participants

Start Date

Jun 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological marker.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how drugs that activate serotonin receptors in the brain affect mood — specifically whether they may have antidepressant effects — in healthy volunteers or individuals with depression. **You may be eligible if...** - You are fluent in English - You have at least a high school education - Your BMI is between 19 and 30 kg/m² **You may NOT be eligible if...** - You have high blood pressure (above 140/90 mmHg) - You have a history of suicidal ideation or a suicide attempt in the past year - You have a serious substance use disorder in the past year - You or a first-degree family member has a history of psychosis - You are currently taking any psychiatric medication (or have been on conventional antidepressants within the last 2 weeks) - You have active panic disorder, severe OCD, or severe PTSD - You are pregnant or planning to become pregnant - You have liver or cardiovascular disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLSD

The serotonin 2A receptor agonist LSD

DRUGPlacebo

Distilled water


Locations(1)

University of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07017478


Related Trials